List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 686 studies with search of: alzheimer disease
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Not yet recruiting Randomized, Controlled Study Evaluating CERE-110 in Subjects With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Genetic: CERE-110: Adeno-Associated Virus Delivery of NGF;   Procedure: Placebo Surgery
2 Recruiting Evaluation of the Efficacy of Varenicline on Cognition, Safety, Tolerability and Pharmacokinetics in Subjects With Mild-to-Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Varenicline;   Drug: Placebo
3 Recruiting Alzheimer's Disease Genetics Study
Conditions: Alzheimer Disease;   Late Onset Alzheimer Disease
Intervention:
4 Recruiting Memantine and Comprehensive, Individualized Management of Alzheimer's Disease and Caregiver Training
Condition: Alzheimer's Disease
Interventions: Behavioral: Individualized management of AD including caregiver training;   Drug: Memantine
5 Recruiting Multiple IV Dose Study Of PF-04360365 In Patients With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Biological: PF-04360365 0.1 mg/kg;   Biological: PF-04360365 0.5 mg/kg;   Biological: PF-04360365 1 mg/kg;   Drug: Placebo;   Biological: PF-04360365 3 mg/kg;   Biological: PF-04360365 8.5 mg/kg
6 Not yet recruiting Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics Study of Bryostatin 1 in Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Bryostatin for Injection;   Drug: Placebo
7 Recruiting Effects of LY450139, on the Progression of Alzheimer's Disease as Compared With Placebo
Condition: Alzheimer's Disease
Interventions: Drug: LY450139;   Drug: Placebo
8 Recruiting Preliminary Efficacy and Safety Study of ST101 in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: ST101;   Drug: ST101;   Drug: ST101;   Drug: Placebo
9 Recruiting Functional Magnetic Resonance Imaging - Synthetic Aperture Magnetometry (fMRI-SAM) and Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Procedure: fMRI to detect MCI patients who will convert to Alzheimer's disease
10 Not yet recruiting Assessment of Sleep Disturbance in Alzheimer Disease
Condition: Alzheimer Disease
Intervention: Other: Analysis of sleep disturbance
11 Recruiting Preliminary Efficacy and Safety Study of ST101 Plus Aricept in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: ST101;   Drug: ST101;   Drug: ST101;   Drug: Placebo
12 Completed Alzheimer's Disease Prevention Trial
Conditions: Alzheimer Disease;   Memory Disorders
Interventions: Drug: Estrogen;   Drug: Estrogen and Progesterone
13 Completed An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's Disease.
Condition: Alzheimer Disease
Intervention: Drug: galantamine
14 Active, not recruiting Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE)
Condition: Alzheimer Disease
Interventions: Drug: alphatocopherol;   Drug: Selenium;   Drug: Placebo replacement for vitamin E;   Drug: Placebo replacement for Selenium
15 Enrolling by invitation Improved Diagnosis of Alzheimer's Disease Using the Synchronous Neural Interaction™ Test
Condition: Alzheimer's Disease
Intervention:
16 Completed CATIE-Alzheimer's Disease Trial
Condition: Alzheimer's Disease
Interventions: Drug: Olanzapine;   Drug: Quetiapine;   Drug: Risperidone;   Drug: Citalopram
17 Completed Study of the Effects of Current Drug Treatments on Levels of Certain Brain Chemicals in Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Rivastigmine
18 Active, not recruiting Far Infrared Treatment for Alzheimer's Disease
Condition: Alzheimer Disease
Intervention: Radiation: Far Infrared Radiation (5μm to 20μm wavelength)
19 Recruiting Life From Vision in Alzheimer Disease
Conditions: Alzheimer Disease;   Cataract
Intervention: Behavioral: Questionaries
20 Completed GTS21-201 for Alzheimer Disease:GTS-21 Administered Daily for 28 Days to Participants With Probable Alzheimer’s Disease
Condition: Alzheimer Disease
Intervention: Drug: DMXB-A

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services